OR51I1
geneOn this page
Summary
OR51I1 (olfactory receptor family 51 subfamily I member 1, HGNC:15200) is a protein-coding gene on chromosome 11p15.4, encoding Olfactory receptor 51I1 (Q9H343). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 390063 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 3 total
- MANE Select transcript:
NM_001005288
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15200 |
| Approved symbol | OR51I1 |
| Name | olfactory receptor family 51 subfamily I member 1 |
| Location | 11p15.4 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000167359 |
| Ensembl biotype | protein_coding |
| Entrez | 390063 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000380211
RefSeq mRNA: 1 — MANE Select: NM_001005288
NM_001005288
CCDS: CCDS31382
Canonical transcript exons
ENST00000380211 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001484111 | 5440570 | 5441514 |
Expression profiles
Bgee: expression breadth tissue_specific, 3 present calls, max score 61.59.
Top tissues by expression
204 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 61.59 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 53.15 | gold quality |
| oocyte | CL:0000023 | 52.20 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 50.78 | gold quality |
| upper leg skin | UBERON:0004262 | 48.18 | silver quality |
| colonic epithelium | UBERON:0000397 | 46.07 | gold quality |
| cardia of stomach | UBERON:0001162 | 46.05 | gold quality |
| skin of hip | UBERON:0001554 | 45.20 | silver quality |
| synovial joint | UBERON:0002217 | 44.10 | gold quality |
| nipple | UBERON:0002030 | 43.75 | gold quality |
| pylorus | UBERON:0001166 | 43.26 | gold quality |
| dorsal root ganglion | UBERON:0000044 | 43.17 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| jejunum | UBERON:0002115 | 42.32 | gold quality |
| buccal mucosa cell | CL:0002336 | 42.29 | gold quality |
| mammalian vulva | UBERON:0000997 | 42.24 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 42.01 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 41.93 | gold quality |
| vastus lateralis | UBERON:0001379 | 41.88 | gold quality |
| quadriceps femoris | UBERON:0001377 | 41.82 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 41.51 | gold quality |
| superficial temporal artery | UBERON:0001614 | 41.33 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 41.10 | gold quality |
| bone marrow cell | CL:0002092 | 41.03 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 40.98 | gold quality |
| right uterine tube | UBERON:0001302 | 40.92 | silver quality |
| mammary duct | UBERON:0001765 | 40.92 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 40.92 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 40.86 | gold quality |
| amniotic fluid | UBERON:0000173 | 40.69 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.63 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or51i1 | ENSMUSG00000066262 |
| rattus_norvegicus | Or51i1 | ENSRNOG00000016954 |
Paralogs (51): OR51E2 (ENSG00000167332), OR51B5 (ENSG00000167355), OR51Q1 (ENSG00000167360), OR52A5 (ENSG00000171944), OR52W1 (ENSG00000175485), OR51B6 (ENSG00000176239), OR51V1 (ENSG00000176742), OR52E2 (ENSG00000176787), OR51L1 (ENSG00000176798), OR51G2 (ENSG00000176893), OR51A7 (ENSG00000176895), OR51T1 (ENSG00000176900), OR51S1 (ENSG00000176922), OR51F2 (ENSG00000176925), OR51E1 (ENSG00000180785), OR56B4 (ENSG00000180919), OR52E4 (ENSG00000180974), OR52N2 (ENSG00000180988), OR52N1 (ENSG00000181001), OR52N5 (ENSG00000181009), OR56B2 (ENSG00000181017), OR56B1 (ENSG00000181023), OR52N4 (ENSG00000181074), OR52P1 (ENSG00000181109), OR52D1 (ENSG00000181609), OR52H1 (ENSG00000181616), OR52K2 (ENSG00000181963), OR52A1 (ENSG00000182070), OR51B4 (ENSG00000183251), OR52E8 (ENSG00000183269), OR52L1 (ENSG00000183313), OR51M1 (ENSG00000184698), OR52B6 (ENSG00000187747), OR51I2 (ENSG00000187918), OR52K1 (ENSG00000196778), OR51D1 (ENSG00000197428), OR51C1 (ENSG00000197674), OR52M1 (ENSG00000197790), OR52E6 (ENSG00000205409), OR52J3 (ENSG00000205495)
Protein
Protein identifiers
Olfactory receptor 51I1 — Q9H343 (reviewed: Q9H343)
Alternative names: Odorant receptor HOR5’beta11, Olfactory receptor OR11-39
All UniProt accessions (2): A0A126GWE7, Q9H343
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_001005288* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
| IPR050402 | OR51/52/56-like | Family |
Pfam: PF13853
UniProt features (20 total): topological domain 8, transmembrane region 7, sequence variant 3, chain 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H343-F1 | 88.80 | 0.69 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 99–191
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 23 (showing top):
GOBP_CELLULAR_RESPONSE_TO_LIPID, GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, GOBP_RESPONSE_TO_LIPID, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, REACTOME_OLFACTORY_SIGNALING_PATHWAY, REACTOME_SENSORY_PERCEPTION
GO Biological Process (6): sensory perception of smell (GO:0007608), cellular response to lipid (GO:0071396), system process (GO:0003008), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), detection of chemical stimulus involved in sensory perception of smell (GO:0050911)
GO Molecular Function (3): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984), signaling receptor activity (GO:0038023)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| sensory perception of chemical stimulus | 1 |
| response to lipid | 1 |
| cellular response to chemical stimulus | 1 |
| multicellular organismal process | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| molecular transducer activity | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
230 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR51I1 | KRTAP12-3 | P60328 | 583 |
| OR51I1 | TMEM235 | A6NFC5 | 518 |
| OR51I1 | C1QTNF8 | P60827 | 437 |
| OR51I1 | TMEM200A | Q86VY9 | 397 |
| OR51I1 | SPATA31D3 | P0C874 | 394 |
| OR51I1 | N4BP2 | Q86UW6 | 371 |
| OR51I1 | CWH43 | Q9H720 | 370 |
| OR51I1 | UBXN11 | Q5T124 | 370 |
| OR51I1 | DUS2 | Q9NX74 | 370 |
| OR51I1 | KLHDC2 | Q9Y2U9 | 357 |
| OR51I1 | PREPL | Q4J6C6 | 352 |
| OR51I1 | CFAP251 | Q8TBY9 | 350 |
| OR51I1 | LHFPL6 | Q9Y693 | 348 |
| OR51I1 | SPATA31D4 | Q6ZUB0 | 348 |
| OR51I1 | GNAL | P38405 | 331 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A3B3IT45, A6NGY5, O88628, P0C646, Q6IFG1, Q8NGF0, Q8NGF1, Q8NGF3, Q8NGH6, Q8NGH7, Q8NGH9, Q8NGI0, Q8NGI2, Q8NGJ2, Q8NGJ3, Q8NGJ4, Q8NGJ5, Q8NGJ6, Q8NGJ7, Q8NGJ9, Q8NGK1, Q8NGK2, Q8NGK3, Q8NGK4, Q8NGK5, Q8NGK6, Q8NH53, Q8NH55, Q8NH56, Q8NH57, Q8NH59, Q8NH60, Q8NH61, Q8NH63, Q8NH64, Q8TCB6, Q8VBV9, Q96RD2, Q96RD3, Q9H255
Diamond homologs: A0A2L0VBG2, E7EM37, E9QJ73, O18821, O18935, O19012, O19014, O19025, O19032, O42329, O62169, O75388, O77700, O77713, O77715, O77721, O77830, O88634, P16395, P30968, P30969, P32236, P32237, P32251, P49651, P49922, P97288, Q01776, Q15722, Q19PY9, Q29003, Q2V2K5, Q6UNA4, Q6XKD3, Q8CH60, Q8JG69, Q8JG70, Q8MJ88, Q8NGA4, Q8SPZ1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
3 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 3 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
211 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:5441023:C:CT | acceptor_gain | 0.9100 |
| 11:5440849:CAA:C | acceptor_gain | 0.7100 |
| 11:5440887:C:CT | acceptor_gain | 0.7000 |
| 11:5440855:G:C | acceptor_gain | 0.6800 |
| 11:5440729:C:CT | acceptor_gain | 0.5800 |
| 11:5441390:A:AC | donor_gain | 0.5800 |
| 11:5441391:C:CC | donor_gain | 0.5800 |
| 11:5440851:A:C | acceptor_gain | 0.5600 |
| 11:5440854:C:CT | acceptor_gain | 0.5600 |
| 11:5441023:C:T | acceptor_gain | 0.5600 |
| 11:5440851:A:AC | acceptor_gain | 0.5500 |
| 11:5440901:A:AC | donor_gain | 0.5500 |
| 11:5440814:T:A | donor_gain | 0.5400 |
| 11:5441025:C:CT | acceptor_gain | 0.5400 |
| 11:5440850:A:T | acceptor_gain | 0.5200 |
| 11:5440855:G:GC | acceptor_gain | 0.5100 |
| 11:5440882:CA:C | acceptor_gain | 0.5000 |
| 11:5441294:C:CA | donor_gain | 0.5000 |
| 11:5440652:A:C | acceptor_gain | 0.4900 |
| 11:5440713:T:A | donor_gain | 0.4800 |
| 11:5440843:C:CT | acceptor_gain | 0.4800 |
| 11:5440722:G:T | acceptor_gain | 0.4700 |
| 11:5440616:T:TA | donor_gain | 0.4500 |
| 11:5440572:AGG:A | donor_gain | 0.4400 |
| 11:5440631:C:CC | acceptor_gain | 0.4400 |
| 11:5440665:A:AC | donor_gain | 0.4300 |
| 11:5440666:C:CC | donor_gain | 0.4300 |
| 11:5440715:C:CT | acceptor_gain | 0.4300 |
| 11:5440883:A:C | acceptor_gain | 0.4300 |
| 11:5440799:G:A | donor_gain | 0.4200 |
AlphaMissense
2079 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:5441203:G:C | F104L | 0.936 |
| 11:5441203:G:T | F104L | 0.936 |
| 11:5441205:A:G | F104L | 0.936 |
| 11:5440756:A:C | F253L | 0.927 |
| 11:5440756:A:T | F253L | 0.927 |
| 11:5440758:A:G | F253L | 0.927 |
| 11:5441005:G:C | F170L | 0.915 |
| 11:5441005:G:T | F170L | 0.915 |
| 11:5441007:A:G | F170L | 0.915 |
| 11:5440973:C:G | C181S | 0.890 |
| 11:5440974:A:T | C181S | 0.890 |
| 11:5441053:A:C | S154R | 0.885 |
| 11:5441053:A:T | S154R | 0.885 |
| 11:5441055:T:G | S154R | 0.885 |
| 11:5441209:C:A | Q102H | 0.885 |
| 11:5441209:C:G | Q102H | 0.885 |
| 11:5441152:G:C | S121R | 0.882 |
| 11:5441152:G:T | S121R | 0.882 |
| 11:5441154:T:G | S121R | 0.882 |
| 11:5440988:A:G | L176S | 0.877 |
| 11:5440958:A:G | L186P | 0.875 |
| 11:5440972:A:C | C181W | 0.871 |
| 11:5441295:C:G | G74R | 0.870 |
| 11:5441295:C:T | G74R | 0.870 |
| 11:5440968:G:C | H183D | 0.868 |
| 11:5441218:G:C | C99W | 0.868 |
| 11:5441188:G:C | F109L | 0.867 |
| 11:5441188:G:T | F109L | 0.867 |
| 11:5441190:A:G | F109L | 0.867 |
| 11:5440924:G:C | N197K | 0.864 |
dbSNP variants (sampled 300 via entrez): RS1000134876 (11:5440654 G>A), RS1001598305 (11:5440922 T>C), RS1002573416 (11:5442468 C>G), RS1002604449 (11:5442103 C>A), RS1003597074 (11:5443360 C>T), RS1003725112 (11:5442803 A>G), RS1004506946 (11:5442706 C>T), RS1006064563 (11:5442513 G>A), RS1006406514 (11:5442666 T>C), RS1007446832 (11:5443291 C>G,T), RS1008255606 (11:5441997 C>G), RS1010648943 (11:5442821 CTT>C), RS1011698475 (11:5441757 G>T), RS1013498388 (11:5441342 T>C), RS1013548927 (11:5441560 G>A,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001862_2 | Sickle cell anemia (haemolysis) | 3.000000e-10 |
| GCST010725_20 | Malaria | 4.000000e-69 |
| GCST010725_33 | Malaria | 2.000000e-67 |
| GCST010725_51 | Malaria | 1.000000e-55 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| theaflavin-3,3’-digallate | affects expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Hydrogen Peroxide | decreases expression | 1 |
| Oxygen | increases expression | 1 |
| Asbestos, Crocidolite | affects expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): sickle cell disease